Osman Kibar

Last updated

Osman Kibar is a Turkish American billionaire. He is the founder of the biotechnology firm Biosplice. [1] [2] [3]

Contents

Early life and education

Kibar was born in İzmir, Turkey, as the grandson of Osman Kibar  [ tr ], who was the mayor of İzmir from 1964 to 1973. [4] His father, Seli Kibar, was an economist. [5]

He attended İzmir Gazipaşa Primary School [6] and then Robert College. For college, he moved to the United States to attend a 3-2 program, studying economics at Pomona College [7] and electrical engineering at Caltech, and receiving a bachelor's degree from both. He did his master's degree and doctorate on biophotonics at UC San Diego.[ citation needed ]

Career

In the late 1990s, when he was finishing his doctorate, he invented a cancer diagnosis system, which he turned into a company called Genoptix. The company went public a few years later, and was purchased by Novartis in 2011 for $476 million. [8]

After completing his education, Kibar moved to New York City, where he worked for the hedge fund sponsor Pequot Capital. [9]

He subsequently moved back to San Diego and in August 2011 founded a biotechnology company named Wintherix with an investment of $3.5 million from his friend Cevdet Samikoğlu. [6] He later renamed the company Samumed, and subsequently Biosplice. [4] Its investors include Ali Sabancı and Ergun Özen. The company researches cures for articular cartilage damage, hair loss, degenerative disc disease, lung tissue regeneration, cancer, psoriasis, damaged tendons, and Alzheimer's disease. [4]

As of November 2020, Kibar has a net worth of $2.9 billion. [10] He ranked eighth on Forbes Turkey's 2017 list of the 100 richest Turks. [11]

Personal life

Kibar is married and has four children. [1] [6]

Despite his wealth, he spends money extremely frugally, saying that all the activities he enjoys, such as reading, playing go, and moviegoing, are free. [6] Kibar is also a successful poker player, and won the first tournament he ever entered in 2006. [12]

Related Research Articles

<span class="mw-page-title-main">Novartis</span> Swiss multinational pharmaceutical corporation

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022.

<span class="mw-page-title-main">Cinema of Turkey</span> Overview of the Turkish cinema

Cinema of Turkey or Turkish cinema, or Türksineması refers to the Turkish film art and industry. It is an important part of Turkish culture, and has flourished over the years, delivering entertainment to audiences in Turkey, Turkish expatriates across Europe, Balkans & Eastern Europe, also more recently prospering in the Arab world and to a lesser extent, the rest of the world.

<span class="mw-page-title-main">Afro-Turks</span> Racial group

Afro-Turks are Turkish people of African Zanj descent, who trace their origin to the Ottoman slave trade like the Afro-Abkhazians. Afro-Turk population is estimated to be between 5,000 and 20,000 people. Afro-Turks are distinct from African immigrants in Turkey, which number around 1.5 million individuals as of 2017 according to state-owned Anadolu Agency.

<span class="mw-page-title-main">Turkish Americans</span> Americans of Turkish birth or descent

Turkish Americans or American Turks are Americans of ethnic Turkish origin. The term "Turkish Americans" can therefore refer to ethnic Turkish immigrants to the United States, as well as their American-born descendants, who originate either from the Ottoman Empire or from post-Ottoman modern nation-states. The majority trace their roots to the Republic of Turkey, however, there are also significant ethnic Turkish communities in the US which descend from the island of Cyprus, the Balkans, North Africa, the Levant and other areas of the former Ottoman Empire. Furthermore, in recent years there has been a significant number of ethnic Turkish people coming to the US from the modern Turkish diaspora, especially from the Turkish Meskhetian diaspora in Eastern Europe and "Euro-Turks" from Central and Western Europe.

<span class="mw-page-title-main">Patrick Soon-Shiong</span> South African billionaire physician, CEO & philanthropist (b. 1952)

Patrick Soon-Shiong is a South African and American businessman, investor, medical researcher, philanthropist, and transplant surgeon. He is the inventor of the drug Abraxane, which became known for its efficacy against lung, breast, and pancreatic cancer. Soon-Shiong is the founder of NantWorks, a network of healthcare, biotech, and artificial intelligence startups; an adjunct professor of surgery and executive director of the Wireless Health Institute at the University of California, Los Angeles; and a visiting professor at Imperial College London and Dartmouth College. Soon-Shiong has published more than 100 scientific papers and has more than 230 issued patents worldwide on advancements spanning numerous fields in technology and medicine.

Mehmet Emin Karamehmet is the chairman of Turkey's Çukurova Holding conglomerate. He was ranked the 2nd wealthiest person in Turkey and the 401st globally in 2012 Forbes Billionaires list. He is one of the most influential and successful businessmen in Turkey with a record of several returns after failures.

Burak Özçivit is a Turkish actor and model who is best known for his roles in Çalıkuşu (2013–2014) and Kara Sevda (2015–2017). He is currently starring as Osman Bey in the history-based, adventure series Kuruluş: Osman (2019–present). Throughout his acting career Özçivit has been a recipient of numerous accolades.

<span class="mw-page-title-main">Turgut Alp</span> Ottoman military commander

Turgut Alp was one of the warriors and alps who fought for Ertuğrul, a Turkoman leader and bey, and Ertuğrul's son Osman I, the founder of the Ottoman Empire. After the establishment of the Empire, he became one of its military commanders, serving Osman I, as well as his son, Orhan Gazi.

Biosplice Therapeutics, Inc. is a private biopharmaceutical company based in San Diego, California. It was founded in 2008 by Osman Kibar.

Kuruluş: Osman is a historical fiction Turkish television series produced by Bozdağ Film. The first episode of the series, directed by Metin Günay and written by Mehmet Bozdağ, was aired on November 20, 2019, on the ATV network. The show is a continuation of the TRT 1 series Diriliş: Ertuğrul, which aired between 2014 and 2019.

<span class="mw-page-title-main">Atatürk, His Mother and Women's Rights Monument</span> Monument in İzmir, Turkey

Atatürk, His Mother and Women's Rights Monument is a monument located at Constitution Square in Karşıyaka district of İzmir, Turkey.

<span class="mw-page-title-main">Ömer Koç</span> Turkish businessman

Mehmet Ömer Koç is a Turkish businessman, art collector, and chairman of Koç Holding. In 2013 Forbes estimated his net worth at US$1.1 billion.

<i>Kuruluş: Osman</i> season 2 Season of Turkish television series

The second season (2020–2021) of the Turkish TV series Kuruluş: Osman, created by Mehmet Bozdağ succeeds the first season of the series. Season two of Kuruluş: Osman is also the seventh season of the two Turkish TV series when including the seasons of Diriliş: Ertuğrul and the second season of the historical drama television series. It premiered on 7 October 2020 and finished on 23 June 2021.

The Siege of Kulacahisar or Raid of Kulacahisar was a battle fought between the Byzantines and the Turks under the command of Osman Gazi in 1285.

<span class="mw-page-title-main">Ertuğrul Bey (fictional character)</span> Fictional character

Ertuğrul Bey is the main protagonist in the Turkish TV series, Diriliş: Ertuğrul, portrayed by Engin Altan Düzyatan. He also appears in the sequel, Kuruluş: Osman, where he is played by Tamer Yiğit and is referred to as Ertuğrul Gazi. The character is based on Ertuğrul, the father of Osman I.

Özge Törer is a Turkish actress known for her role as Bala Hatun in the Turkish TV series Kuruluş Osman, in which she stars alongside Burak Özçivit.

References

  1. 1 2 Herper, Matthew (May 10, 2016). "Cure Baldness? Heal Arthritis? Erase Wrinkles? An Unknown Billionaire's Quest To Reverse Aging". Forbes . Retrieved July 29, 2020.
  2. ↑ "Osman Kibar kimdir?". Milliyet (in Turkish). April 15, 2016. Retrieved August 30, 2020.
  3. ↑ Amirah, Al Idrus (August 15, 2019). "In conversation with Samumed CEO Osman Kibar: Drugging Wnt, restoring youth and unconventional capital". FierceBiotech . Retrieved August 30, 2020.
  4. 1 2 3 "50 milyar $'a koşan türk" (in Turkish). capital.com.tr. December 10, 2018. Archived from the original on September 25, 2019. Retrieved November 2, 2020.
  5. ↑ "İşadamı Seli Kibar yaşama veda etti" (in Turkish). yeniasir.com.tr. May 29, 2014. Archived from the original on September 25, 2019. Retrieved November 2, 2020.
  6. 1 2 3 4 "İzmir'den yola çıktı Amerika'da başardı" (in Turkish). Sözcü (gazete). July 20, 2019. Archived from the original on July 20, 2019. Retrieved November 2, 2020.
  7. ↑ Norwood, Robyn (October 25, 2016). "How to Build a Fountain of Youth (Piece by Piece)". Pomona College Magazine. Pomona College . Retrieved August 30, 2020.
  8. ↑ "Genoptix Announces Agreement to be Acquired by Novartis". PR Newswire . January 24, 2011. Retrieved December 18, 2023.
  9. ↑ Meiling, Brittany (April 25, 2016). "Out of the Shadows". San Diego Business Journal. Retrieved December 18, 2023.
  10. ↑ "Osman Kibar". Forbes. Retrieved December 4, 2020.
  11. ↑ "İşte Türkiye'nin en zengin 50 ismi" (in Turkish). CNN Türk. March 3, 2017. Archived from the original on November 12, 2017. Retrieved November 12, 2017.
  12. ↑ Dunehew, Nick (July 18, 2020). "Osman Kibar Biography". Brooksy. Retrieved December 8, 2020.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.